These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35268536)

  • 1. Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It.
    Yen PC; Chou YT; Li CH; Sun ZJ; Wu CH; Chang YF; Lu FH; Yang YC; Chang CJ; Wu JS
    J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease.
    Zhou M; Yang N; Xing X; Chang D; Li J; Deng J; Chen Y; Hu C; Zhang R; Lu X; Zhao Y; He Y
    BMC Gastroenterol; 2021 Jan; 21(1):43. PubMed ID: 33509116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study.
    Yang C; Yang S; Feng C; Zhang C; Xu W; Zhang L; Yan Y; Deng J; Ohore OE; Li J
    PLoS One; 2018; 13(2):e0192396. PubMed ID: 29415050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study.
    Yu XL; Shu L; Shen XM; Zhang XY; Zheng PF
    Medicine (Baltimore); 2017 Sep; 96(39):e8164. PubMed ID: 28953666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
    Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
    Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum uric acid and nonalcoholic fatty liver disease in the US population.
    Shih MH; Lazo M; Liu SH; Bonekamp S; Hernaez R; Clark JM
    J Formos Med Assoc; 2015 Apr; 114(4):314-20. PubMed ID: 25839764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaruvongvanich V; Ahuja W; Wijarnpreecha K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):694-697. PubMed ID: 28252464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
    Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
    Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaruvongvanich V; Ahuja W; Wirunsawanya K; Wijarnpreecha K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1031-1035. PubMed ID: 28639970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center.
    Sandra S; Lesmana CRA; Purnamasari D; Kurniawan J; Gani RA
    Diabetes Metab Syndr; 2019; 13(1):424-428. PubMed ID: 30641737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.
    Yang C; Yang S; Xu W; Zhang J; Fu W; Feng C
    PLoS One; 2017; 12(5):e0177249. PubMed ID: 28510581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses.
    Ma Z; Zhang J; Kang X; Xu C; Sun C; Tao L; Zheng D; Han Y; Li Q; Guo X; Yang X
    Atherosclerosis; 2020 Oct; 311():44-51. PubMed ID: 32937242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
    Fernández Rodríguez CM; Aller R; Gutiérrez García ML; Ampuero J; Gómez-Camarero J; Martín-Mateos RMª; Burgos-Santamaría D; Rosales JM; Aspichueta P; Buque X; Latorre M; Andrade RJ; Hernández-Guerra M; Romero-Gómez M
    Rev Esp Enferm Dig; 2019 Apr; 111(4):264-269. PubMed ID: 30810330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver.
    Golmohammadi S; Tavasoli M; Asadi N
    Clin Exp Gastroenterol; 2020; 13():299-304. PubMed ID: 32903892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Clin Gastroenterol; 2006 Sep; 40(8):745-52. PubMed ID: 16940890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study.
    Xu K; Zhao X; Fu X; Xu K; Li Z; Miao L; Li Y; Cai Z; Qiao L; Bao J
    Biomed Pharmacother; 2019 Sep; 117():109158. PubMed ID: 31252266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease.
    Huang Q; Yu J; Zhang X; Liu S; Ge Y
    Biomed Rep; 2016 Aug; 5(2):188-192. PubMed ID: 27446539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of serum uric acid with non-alcoholic fatty liver disease.
    Sertoglu E; Ercin CN; Celebi G; Gurel H; Kayadibi H; Genc H; Kara M; Dogru T
    Clin Biochem; 2014 Apr; 47(6):383-8. PubMed ID: 24525254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.